| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Lisitinib | GDSC1000 | pan-cancer | AAC | 0.085 | 0.03 |
| mRNA | UNC0638 | GDSC1000 | pan-cancer | AAC | -0.074 | 0.03 |
| mRNA | HG-5-113-01 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.03 |
| mRNA | OSI-027 | GDSC1000 | pan-cancer | AAC | -0.076 | 0.03 |
| mRNA | Imatinib | GDSC1000 | pan-cancer | AAC | 0.13 | 0.03 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | 0.12 | 0.03 |
| mRNA | etoposide | GDSC1000 | pan-cancer | AAC | -0.085 | 0.03 |
| mRNA | etomoxir | CTRPv2 | pan-cancer | AAC | 0.085 | 0.03 |
| mRNA | BRD-K09587429 | CTRPv2 | pan-cancer | AAC | -0.088 | 0.03 |
| mRNA | masitinib | GDSC1000 | pan-cancer | AAC | 0.077 | 0.03 |